Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $938.73 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inari Medical, Inc. | $217.74 | 1 | $0 (2022) |
| Novo Nordisk Inc | $162.07 | 7 | $0 (2024) |
| ABBVIE INC. | $153.91 | 7 | $0 (2024) |
| PFIZER INC. | $141.20 | 7 | $0 (2023) |
| Amarin Pharma Inc. | $45.41 | 2 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $29.80 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $26.51 | 2 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $23.97 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $23.80 | 1 | $0 (2021) |
| Exact Sciences Corporation | $23.19 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.80 | 6 | ABBVIE INC. ($70.88) |
| 2023 | $214.10 | 9 | Novo Nordisk Inc ($69.74) |
| 2022 | $263.17 | 3 | Inari Medical, Inc. ($217.74) |
| 2021 | $180.72 | 9 | PFIZER INC. ($120.87) |
| 2020 | $93.90 | 5 | Amarin Pharma Inc. ($28.20) |
| 2019 | $43.58 | 3 | Amarin Pharma Inc. ($17.21) |
| 2017 | $22.46 | 2 | GlaxoSmithKline, LLC. ($22.46) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/08/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Oncology | ||||||
| 07/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Diabetes | ||||||
| 04/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Diabetes | ||||||
| 04/19/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Neuroscience | ||||||
| 01/18/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: NEUROSCIENCE | ||||||
| 04/28/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $217.74 | General |
| Category: VTE | ||||||
| 03/02/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Diabetes | ||||||
| 09/23/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/18/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/21/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/14/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/03/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/30/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/25/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,124 | 1,453 | $252,910 | $106,867 |
| 2022 | 19 | 1,357 | 1,753 | $298,112 | $122,434 |
| 2021 | 21 | 1,940 | 2,513 | $391,035 | $180,445 |
| 2020 | 22 | 1,833 | 2,360 | $353,410 | $150,969 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 296 | $65,120 | $28,475 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 129 | 129 | $38,700 | $17,205 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 183 | 225 | $33,750 | $13,727 | 40.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 73 | 200 | $30,038 | $12,977 | 43.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 57 | $20,165 | $8,052 | 39.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 57 | 72 | $17,694 | $6,583 | 37.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 62 | $12,504 | $5,989 | 47.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 25 | $8,750 | $5,566 | 63.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 21 | $5,775 | $3,540 | 61.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,889 | $1,398 | 35.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 29 | $2,755 | $1,100 | 39.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 96 | 100 | $8,000 | $955.11 | 11.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 17 | $1,700 | $732.70 | 43.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 142 | 154 | $3,080 | $336.60 | 10.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 39 | 39 | $780.00 | $158.73 | 20.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 14 | 14 | $210.00 | $71.12 | 33.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 167 | 462 | $90,300 | $39,476 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 134 | 134 | $40,200 | $18,416 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 188 | $41,360 | $15,710 | 38.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 92 | 96 | $34,364 | $15,493 | 45.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 132 | 143 | $32,454 | $12,552 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 209 | $31,350 | $10,606 | 33.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 17 | 17 | $4,425 | $2,948 | 66.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $4,756 | $1,916 | 40.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 66 | 66 | $1,980 | $1,290 | 65.1% |
About Dr. Gordon Newsom, M.D
Dr. Gordon Newsom, M.D is a Internal Medicine healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508929480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gordon Newsom, M.D has received a total of $938.73 in payments from pharmaceutical and medical device companies, with $120.80 received in 2024. These payments were reported across 37 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($938.73).
As a Medicare-enrolled provider, Newsom has provided services to 6,254 Medicare beneficiaries, totaling 8,079 services with total Medicare billing of $560,716. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Elgin, IL
- Active Since 12/19/2006
- Last Updated 12/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508929480
Products in Payments
- FLOWTRIEVER CATHETER, S (Device) $217.74
- ELIQUIS (Drug) $141.20
- Ozempic (Drug) $140.27
- QULIPTA (Drug) $113.95
- Vascepa (Drug) $45.41
- UBRELVY (Drug) $39.96
- INVOKANA (Drug) $29.80
- FARXIGA (Drug) $26.51
- REXULTI (Drug) $23.97
- ENTRESTO (Drug) $23.80
- Cologuard Collection Kit (Device) $23.19
- ZENPEP (Drug) $22.64
- ADVAIR (Drug) $22.46
- Rybelsus (Drug) $21.80
- EMGALITY (Drug) $19.78
- SPIRIVA RESPIMAT (Drug) $13.27
- XIFAXAN (Drug) $12.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elgin
Mr. Michael Hernandez, M.d, M.D
Internal Medicine — Payments: $26,674
Dr. Robert Tiballi, D.o, D.O
Internal Medicine — Payments: $20,485
Paula Belmar, Md, MD
Internal Medicine — Payments: $12,301
Dr. Heena Shyamani, M.d, M.D
Internal Medicine — Payments: $12,014
Mr. Richard Baley, M.d, M.D
Internal Medicine — Payments: $11,178
John Adams, Md, MD
Internal Medicine — Payments: $10,883